Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
| LYFAX Fund | USD 13.70 0.04 0.29% |
Slightly above 54% of Alphacentric Lifesci's investor base is interested to short. The analysis of overall sentiment of trading Alphacentric Lifesci Healthcare mutual fund suggests that many investors are impartial at this time. Alphacentric Lifesci's investing sentiment can be driven by a variety of factors including economic data, Alphacentric Lifesci's earnings reports, geopolitical events, and overall market trends.
Alphacentric |
DUBLIN, August 23, 2023 Horizon Therapeutics plc today announced that it ranked first in overall corporate reputation among rare disease patient groups around the world who were familiar with the company. Rare disease patient groups who worked with Horizon also ranked the company first in 10 of the 14 indicators including patient centricity, patient information, integrity, access to medicines, relationships and services bey
Read at finance.yahoo.com
 |
Alphacentric Lifesci Fundamental Analysis
We analyze Alphacentric Lifesci's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alphacentric Lifesci using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alphacentric Lifesci based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Three Year Return
Three Year Return Comparative Analysis
Alphacentric Lifesci is currently under evaluation in three year return among similar funds. Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
Alphacentric Lifesci Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alphacentric Lifesci mutual fund to make a market-neutral strategy. Peer analysis of Alphacentric Lifesci could also be used in its relative valuation, which is a method of valuing Alphacentric Lifesci by comparing valuation metrics with similar companies.
Peers
Alphacentric Lifesci Related Equities
| SHSKX | Blackrock Health | 0.49 | ||||
| SHISX | Blackrock Health | 0.27 | ||||
| ITRAX | Vy(r) T | 0.04 | ||||
| ERSMX | Eaton Vance | 0.33 |
Other Information on Investing in Alphacentric Mutual Fund
Alphacentric Lifesci financial ratios help investors to determine whether Alphacentric Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alphacentric with respect to the benefits of owning Alphacentric Lifesci security.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |